SLS

NASDAQStock

SELLAS Life Sciences Group, Inc.

$5.29+0.26 (+5.07%)

52-Week Range

$1.04
$5.96

Key Stats

Market Cap

752.8M

P/E Ratio

Dividend Yield

Beta

2.21

Volume

5.3M

Avg Volume

7.9M

Performance

1M

+41.69%

3M

+146.57%

6M

+199.40%

YTD

+15.63%

1Y

+341.23%

3Y

+264.49%

5Y

-54.48%

Price Chart

ETF Exposure

SLS is held by 40 ETFs

ETFFund NameWeight
CANCTema Oncology ETF0.29%
VFMOVanguard U.S. Momentum Factor ETF0.16%
IWCiShares Micro-Cap ETF0.14%
VMO.TOVanguard Global Momentum Factor ETF0.10%
IWOiShares Russell 2000 Growth ETF0.04%
VTWGVanguard Russell 2000 Growth ETF0.03%
IWMiShares Russell 2000 ETF0.02%
SC0K.DEInvesco Russell 2000 UCITS ETF0.02%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.02%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.02%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.02%
RESMColumbia Research Enhanced Small Cap ETF0.02%
RSSLGlobal X - Russell 2000 ETF0.02%
UWMProShares - Ultra Russell20000.01%
VTWOVanguard Russell 2000 ETF0.01%
R2SC.LState Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)0.01%
URTYProShares - UltraPro Russell20000.01%
VXFVanguard Extended Market ETF0.01%
SMMDiShares Russell 2500 ETF0.01%
HDGProShares - Hedge Replication ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%

About SLS ETF Exposure

SELLAS Life Sciences Group, Inc. (SLS) is held by 40 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 752.8M, SLS is a widely held institutional stock. The stock currently trades at $5.29. Investors can gain exposure to SLS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SLS, sorted by portfolio weight.